1179 related articles for article (PubMed ID: 33941393)
1. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
Sharun K; Dhama K
Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
[TBL] [Abstract][Full Text] [Related]
2. India's role in COVID-19 vaccine diplomacy.
Sharun K; Dhama K
J Travel Med; 2021 Oct; 28(7):. PubMed ID: 33870417
[TBL] [Abstract][Full Text] [Related]
3. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
So AD; Woo J
BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
5. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
Suárez-Álvarez A; López-Menéndez AJ
J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform.
Chattu VK; Singh B; Kaur J; Jakovljevic M
Biomed Res Int; 2021; 2021():6658070. PubMed ID: 34485525
[TBL] [Abstract][Full Text] [Related]
7. Clinical development and approval of COVID-19 vaccines.
Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P
Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542
[TBL] [Abstract][Full Text] [Related]
8. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Vaccine Donations-Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review.
Su Z; McDonnell D; Li X; Bennett B; Šegalo S; Abbas J; Cheshmehzangi A; Xiang YT
Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579261
[No Abstract] [Full Text] [Related]
10. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
Pilkington V; Keestra SM; Hill A
Front Public Health; 2022; 10():821117. PubMed ID: 35321196
[TBL] [Abstract][Full Text] [Related]
11. Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.
Oberemok VV; Andreeva OA; Laikova KV; Novikov IA; Puzanova YV; Kubyshkin AV
Inflamm Res; 2022 Jun; 71(5-6):521-536. PubMed ID: 35397666
[TBL] [Abstract][Full Text] [Related]
12. Competing Responses to Global Inequalities in Access to COVID Vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
Sparke M; Levy O
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S86-S92. PubMed ID: 35535787
[TBL] [Abstract][Full Text] [Related]
13. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
Eccleston-Turner M; Upton H
Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
[TBL] [Abstract][Full Text] [Related]
14. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
Aida T; Shoji M
BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
[TBL] [Abstract][Full Text] [Related]
15. A Community Partnered Approach to Promoting COVID-19 Vaccine Equity.
Scott T; Gutschow B; Ragavan MI; Ho K; Massart M; Ripper L; Muthama V; Miller E; Bey J; Abernathy RP
Health Promot Pract; 2021 Nov; 22(6):758-760. PubMed ID: 34311592
[TBL] [Abstract][Full Text] [Related]
16. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
[No Abstract] [Full Text] [Related]
17. COVID-19 vaccine and the cold chain implications for global adoption.
Das MK
Indian J Public Health; 2021; 65(3):307-310. PubMed ID: 34558497
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
Dhama K; Sharun K; Tiwari R; Dhawan M; Emran TB; Rabaan AA; Alhumaid S
Hum Vaccin Immunother; 2021 Oct; 17(10):3495-3499. PubMed ID: 34191680
[TBL] [Abstract][Full Text] [Related]
19. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan KL; MacIntyre CR; McIntyre PB; Nelson MR
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3535-3543. PubMed ID: 34400116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
